Skip to content

Clinical trials

Phase 2 Hodgkin Disease trials in Canada

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Hodgkin Disease Phase: Phase 2 Country / region: Canada Clear all

17 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20011
20041
20061
20092
20102
20121
20141
20171
20191
20211
20222

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed15
Recruiting1
Terminated1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Children's Oncology Group3
Bristol-Myers Squibb2
Merck Sharp & Dohme LLC2
Seagen Inc.2
ADC Therapeutics S.A.1
Alliance for Clinical Trials in Oncology1
Amgen1
Canadian Cancer Trials Group1
Mirati Therapeutics Inc.1
NCIC Clinical Trials Group1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Hodgkin Disease17
Lymphoma10
Recurrence4
Lymphoma, Non-Hodgkin3
Hematologic Diseases2
Breast Neoplasms1
Carcinoma, Non-Small-Cell Lung1
Colonic Neoplasms1
Endocrine Gland Neoplasms1
Head and Neck Neoplasms1

Trials

Showing 1 to 17 of 17. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.